Acrivon Therapeutics Company
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Technology:
Others
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2018
Employees Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
115500000
Last Funding Type:
Series B
Register and Claim Ownership